Preview Mode Links will not work in preview mode

Clinical Literature Summaries presented by InpharmD™ (S3)


Mar 14, 2022

A prospective, double blind, superiority, randomized placebo-controlled trial conducted to confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks.